Candriam S.C.A. Axsome Therapeutics, Inc. Transaction History

Candriam S.C.A.

$15.4 Billion
Q1 2024

A detailed history of Candriam S.C.A. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 75,084 shares of AXSM stock, worth $5.93 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

75,084

Previous 85,084 11.75%

Holding current value

$5.93 Million

Previous $6.77 Million 11.52%

% of portfolio

0.04%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$69.39 - $97.64 $693,900 - $976,400	-10,000 Reduced 11.75%	75,084 $5.99 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $2.01 Million - $2.93 Million	35,000 Added 69.88%	85,084 $6.77 Million
Q2 2023 Aug 08, 2023	SELL	$58.41 - $90.35 $2.63 Million - $4.07 Million	-45,000 Reduced 47.33%	50,084 $3.6 Million
Q1 2023 May 12, 2023	SELL	$58.39 - $75.0 $4.46 Million - $5.73 Million	-76,390 Reduced 44.55%	95,084 $5.86 Million
Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $2.44 Million - $4.87 Million	61,094 Added 55.35%	171,474 $13.2 Million

Q3 2022 Nov 10, 2022	SELL	$36.06 - $69.85 $169,626 - $328,574	-4,704 Reduced 4.09%	110,380 $4.93 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $491,229 - $857,890	20,727 Added 21.97%	115,084 $4.76 Million
Q4 2021 Feb 10, 2022	SELL	$30.7 - $43.36 $1.82 Million - $2.57 Million	-59,245 Reduced 38.57%	94,357 $3.57 Million
Q3 2021 Nov 09, 2021	BUY	$19.91 - $68.26 $696,850 - $2.39 Million	35,000 Added 29.51%	153,602 $5.06 Million
Q2 2021 Jul 20, 2021	BUY	$50.63 - $73.5 $141,764 - $205,800	2,800 Added 2.42%	118,602 $8 Million
Q4 2020 Jan 22, 2021	BUY	$66.31 - $86.52 $1.02 Million - $1.33 Million	15,347 Added 15.28%	115,802 $9.44 Million
Q3 2020 Oct 19, 2020	BUY	$68.34 - $85.84 $6.87 Million - $8.62 Million	100,455 New	100,455 $7.16 Million

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account